Novel deletion mutation of HLA-B*40:02 gene in acquired aplastic anemia.

about

Novel deletion mutation of HLA-B*40:02 gene in acquired aplastic anemia.

Item

http://www.wikidata.org/entity/Q39062911

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Novel deletion mutation of HLA-B*40:02 gene in acquired aplastic anemia.

@en

Novel deletion mutation of HLA-B*40:02 gene in acquired aplastic anemia.

@nl

type

Item

label

Novel deletion mutation of HLA-B*40:02 gene in acquired aplastic anemia.

@en

Novel deletion mutation of HLA-B*40:02 gene in acquired aplastic anemia.

@nl

prefLabel

Novel deletion mutation of HLA-B*40:02 gene in acquired aplastic anemia.

@en

Novel deletion mutation of HLA-B*40:02 gene in acquired aplastic anemia.

@nl

P1476

Novel deletion mutation of HLA-B*40:02 gene in acquired aplastic anemia.

@en

P2093

D Seo

http://www.w3.org/2001/XMLSchema#string

H-S Chung

http://www.w3.org/2001/XMLSchema#string

J Huh

http://www.w3.org/2001/XMLSchema#string

J Im

http://www.w3.org/2001/XMLSchema#string

P2860

Autoantibodies frequently detected in patients with aplastic anemia.

The pathophysiology of acquired aplastic anemia.

Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia.

HGVS Recommendations for the Description of Sequence Variants: 2016 Update.

Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia

Diagnosis of acquired aplastic anemia.

Current concepts in the pathophysiology and treatment of aplastic anemia.

Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia.

Somatic mutation in acute myelogenous leukemia cells imitate novel germline HLA-A allele: a case report.

In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.

P304

47-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TAN.12943

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yeung-Chul Mun

Tae-Dong Jeong

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28025876

http://www.w3.org/2001/XMLSchema#string